Double Filtration Plasmapheresis Combined With Chemotherapy

  • STATUS
    Recruiting
  • End date
    Oct 31, 2024
  • participants needed
    20
  • sponsor
    Fuling Zhou
Updated on 24 July 2021
bone marrow procedure
chemotherapy regimen

Summary

Evaluation of double filtration plasmapheresis combined with chemotherapy for the treatment of abnormalities of M protein or renal function due to the multiple myeloma.

Details
Condition Multiple Myeloma, Lymphoproliferative Disorder, multiple myeloma (mm)
Treatment DFPP combined with chemotherapy
Clinical Study IdentifierNCT04836871
SponsorFuling Zhou
Last Modified on24 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Multiple myeloma patients who are diagnosed by bone marrow morphology and immunology
Patients with stable condition after conventional treatment
Patients with renal insufficiency or abnormal M protein
Patients over 18 years of age
Liver function: blood bilirubin 35mol/L, enzymes aspartate transaminase (AST)/aka alanine aminotransferase (ALT) is less than 2 times the upper limit of normal
Normal heart function
Physical condition score 0-2 level (ECOG score)
Obtain an informed consent form signed by the patient or family member

Exclusion Criteria

Allergies or obvious contraindications to any of the drugs involved in the plan
Severe heart disease, including myocardial infarction and cardiac insufficiency
Suffering from other organ malignancies
Active tuberculosis patients and HIV-positive patients
At the same time suffering from other blood system diseases
Pregnant or lactating women
Able to understand or follow the research plan
Past history of intolerance or allergy to similar drugs
Patients under 18 years of age
Participating in other clinical researchers at the same time
There are any other circumstances that hinder the progress of the research
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note